Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Revenue - Other
Ratios

Aclaris Therapeutics (ACRS) Leases (2019 - 2020)

Historic Leases for Aclaris Therapeutics (ACRS) over the last 2 years, with Q3 2020 value amounting to $435000.0.

  • Aclaris Therapeutics' Leases changed 0.0% to $435000.0 in Q3 2020 from the same period last year, while for Sep 2020 it was $435000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $435000.0 for FY2019, which is N/A changed from last year.
  • As of Q3 2020, Aclaris Therapeutics' Leases stood at $435000.0, which was down 0.0% from $435000.0 recorded in Q2 2020.
  • Aclaris Therapeutics' Leases' 5-year high stood at $2.6 million during Q1 2019, with a 5-year trough of $435000.0 in Q3 2019.